ESMO 2018: Major response to immunotherapy in early stage mismatch repair deficient colon cancer
Pre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major…
Pre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major…
Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic…
Professor Dirk Haller and his team, from the Department of Nutrition and Immunology at the…
The world’s first clinical trial (SURGUVANT) evaluating anti-inflammatory use at the time of surgery in…
Drinking artificially-sweetened beverages is associated with a significantly lower risk of colon cancer recurrence and…
Princeton researchers have developed a new computational method that increases the ability to track the…
Disease progression in patients with colon cancer can now be defined more accurately with Immunoscore,…
Researchers have identified a correlation between microbiomand microRNA expression in human colorectal cancer, according to…
Two common iron compounds increase the formation of a known biomarker for cancer, according to…
A lifestyle consistent with the American Cancer Society (ACS) guidelines to maintain a healthy weight,…